MEBO Private Facebook Group
to join : contact
maria.delatorre@meboresearch.org

MEBO TMAU urine test

MEBO Research
TMAU Urine Test
United States only
PROGRAM IS PERMANENTLY SUSPENDED AS OF 2 MAY 2017

Click here for
REQUISITION FORM
Incomplete applications
will NOT be processed

SEE UPDATES HERE

1
test
$150 plus
shipping costs
2
tests
$250 plus
shipping costs

TWO PAYMENT PLAN OPTION
Send email to maria.delatorre@meboresearch.org to arrange, AFTER filling out Requisition Form, please.

Test analysis performed in batches of 20 or more

DATE: 2 MAY 2017
Currently on : PROGRAM IS TEMPORARILY SUSPENDED

Samples analyzed since June 2012 :
352
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

MEBO meetup map


Full details : https://goo.gl/TMw8xu
want listed ? contact map@meboresearch.org
BannerFans.com
RESEARCH DETAILS

DONATIONS THRU 31-NOV-2016:
£ 943.03/GBP
$ 568.00/USD

TOTAL at today's ROE
£0.80/GBP = $1.00/USD

£1,398.07 = $1,745.14

MEBO UK PAYPAL FOR TRINZYME

********
MEBO US PAYPAL FOR TRINZYME

Your currency will be automatically converted to USD or GBP by PayPal.

Option: pay with your credit card instead of PayPal account by clicking on either Donate button above.

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

Thursday, March 29, 2012

MEBO Research is a National Member Organization with NORD


MEBO's NORD Membership
Application is Approved


I am most excited to announce that NORD's Board of Directors has approved the application for MEBO Research, Inc., as one of NORD's member organizations. As a National Member Organization,we are now proud to be on the "CURRENT LIST OF MEMBER ORGANIZATIONS," and as such, we are encouraged by NORD to display the NORD's Member Organzation Logo on our website and blogs.

WHAT ARE THE BENEFITS OF MEMBERSHIP:
As a member of the NORD membership community, we join the conversation and bring the power of more voices together to achieve mutual goals on behalf of patients and families affected by rare diseases. With broad representation on a geographic and disease-specific basis, NORD can have greater influence on advocacy efforts that benefit all patients with rare diseases.

    BENEFITS OF BEING A NATIONAL MEMBER ORGANIZATION:
  1. Advocacy
  2. Policy Development
    • NORD maintains an aggressive public policy agenda that continues to focus on such key issues as maintaining Health Care insurance reforms and elimination of annual and lifetime caps, expanding SSA Compassionate Allowances, achieving coverage of medical foods, and supporting development of new therapies
  3. Critical Issues Analysis: NORD provides members with analyses of legislative and regulatory activity and public policy that will impact the rare disease community
  4. Education: Member organizations are supported with ongoing educational webinars on policy issues and the public policy process, as well as access to senior level representatives within the FDA, NIH, CMS, and other governmental agencies.
  5. Opportunities to Connect: NORD provides member organizations with the opportunity to connect and gain access to the knowledge base within the membership community and to learn and share best practices on issues of similar concern. These can be related to public policy, or to developing their organization, building capacity and meeting the needs of the patients they represent.
  6. Research Support: NORD supports the research efforts of member organizations through information-sharing related to sources of research funding. NORD also administers a limited number of research grants.
  7. Member Organization Visibility: NORD partners with its members to create greater awareness for them throughout all NORD communications materials and the website, through listing of member activities and events, and attendance at select medical meetings. Patients who contact NORD are also referred to the appropriate member organization.
  8. Voting Privileges: National Member Organizations are eligible to vote for the NORD Board of Directors, as well as on agenda items at the NORD annual meeting.


CRITERIA FOR ORGANIZATIONAL MEMBERSHIP IN NORD
In order to qualify for National Membership, MEBO had to fill the following qualifications:
  1. Proof of 501(c)(3) tax exempt non-profit status...
  2. Dated by-laws with Mission statement compatible with NORD's goals of being patient-centered, and advocating on behalf of patients in the rare disease community.
    • Names and addresses for a minimum of five board members. MEBO currently has five (5) registered board members in the United States. Although for this National Member Organization application only the listing of the board members of the US charity were required, MEBO also enjoys the support of an additional five (5) member Board registered in England and Wales.
    • Minimum of three (3) medical/scientific advisors in place. MEBO is most grateful to the following five (5) experts who consented to be our Medical / Scientific Advisors,

        John R. Cashman, Ph.D. President and Founder Human BioMolecular Research Institute (HBRI) Professor Elizabeth A. Shephard Vice Dean Education, Biosciences Institute of Structural and Molecular Biology Division of Biosciences Darwin Building UCL Genetics Institute University College London Nigel Manning Principal Clinical Scientist Department of Clinical Chemistry Sheffield Children's Hospital Sheffield, England Irene Gabashvili, Ph.D. Director, Scientific Advisor MEBO Research, Inc. Colin Harvey-Woodworth, BDS Director, Scientific Advisor MEBO Research

    • Annual Budget approved by the Board.
  3. Policy Requirements:

    • Policies on conflict-of-interest for Board and Staff
    • Privacy policy that protects the identity of patients and families.

In support of MEBO's Privacy policy, MEBO Research, Inc., has formed and registered an Institutional Review Board (IRB) to oversee all of MEBO's studies involving human subjects to assure that the Federal Policy for the Protection of Human Subjects are adhered to.

It has been, and will continue to be, MEBO Research's focus to establish a strong foundation upon which our international community of sufferers can rest to find organizational strength in order to bring about substantial changes to sufferers' lives by initiating research to find the proper treatment for all types of body odor conditions, including rare diseases, such as TMAU and other yet-to-be-defined genetic conditions that result in chronic and difficult to control body and breath malodor.

María

María de la Torre
Founder and Executive Director

A Public Charity
www.meboresearch.org
www.brasil.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)



SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation to MEBO.


Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


A EURORDIS and NORD Member Organization

2 comments:

Anonymous said...

That's great news

-Inconceivable

Mar 29, 2012, 3:57:00 PM
Pete said...

Great work to everyone in the community especially Maria. Hang in there everyone we are making progress. Im sure in a few years time we will be cured.

Mar 31, 2012, 4:08:00 AM
Post a Comment